Cutaneous Myelofibrosis With JAK2 V617F Mutation: Metastasis, Not Merely Extramedullary Hematopoiesis!

被引：11

作者：

Fraga, Garth R. ^{[1
]}

Caughron, Samuel K. ^{[2
]}

机构：

[1] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA

[2] MAWD Pathol Grp, Kansas City, MO USA

来源：

AMERICAN JOURNAL OF DERMATOPATHOLOGY | 2010年 / 32卷 / 07期

关键词：

myelofibrosis; extramedullary hematopoiesis; metastasis; JAK2; leukemia; MYELOID METAPLASIA; IDIOPATHIC MYELOFIBROSIS; SKIN; MANIFESTATION; PATHOGENESIS;

D O I：

10.1097/DAD.0b013e3181d3ca2f

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm. There are 31 reported cases of cutaneous involvement by PMF, most of which have been described as "extramedullary hematopoiesis.'' We report a new case of cutaneous involvement by PMF and demonstrate mutation of the Janus kinase 2 gene in the cutaneous lesions. Extramedullary myelofibrosis is best considered a metastatic phenomenon. Reporting such cases as extramedullary hematopoiesis may cause confusion with reactive forms of extramedullary hematopoiesis.

引用

页码：727 / 730

页数：4

共 50 条

[11] The JAK2 V617F mutation in essential thrombocythemia
Cho, Young-Uk
Chung, Hee-Jung
Chi, Hyun-Sook
Jang, Seoungsoo
Park, Chan-Jeoung
Lee, Jung-Hee
Lee, Je-Hwan
Lee, Kyoo-Hyung
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 103 - 103
[12] The JAK2 V617F mutation in breast cancer?
Naeem, Mohammad Abdul
BREAST JOURNAL, 2020, 26 (03): : 593 - 593
[13] THE JAK2 V617F MUTATION IN ISOLATED NEUTROPENIA
Langabeer, Stephen E.
EXCLI JOURNAL, 2018, 17 : 1 - 2
[14] The JAK2 V617F mutation in patients with anaemia
Langabeer, S. E.
IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (02) : 349 - 350
[15] The V617F JAK2 mutation and the myeloproliferative disorders
Percy, MJ
McMullin, MF
HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
[16] STUDY OF MYELOFIBROSIS USING JAK2 V617F EXPRESSING MACROPHAGES
Silyutina, Anna
Gin, Irina
Prikhodko, Stanislava
Butylin, Pavel
Zaritskey, Andrey
EXPERIMENTAL HEMATOLOGY, 2017, 53 : S65 - S65
[17] The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis
Yip, SF
So, CC
Chan, AYY
Liu, HSY
Wan, TSK
Chan, LC
LEUKEMIA, 2006, 20 (06) : 1165 - 1165
[18] Incidence and clinical profile of JAK2 V617F mutation in myelofibrosis with myeloid metaplasia.
Barosi, G
Marchetti, M
Massa, M
Rosti, V
Vannucchi, A
Invernizzi, R
Campanelli, R
Viarengo, G
Magrini, U
Bergamaschi, G
BLOOD, 2005, 106 (11) : 78A - 78A
[19] Monocytes with Oncogenic Mutation JAK2 V617F as a Tool for Studies of the Pathogenic Mechanisms of Myelofibrosis
Silyutina, A. A.
Gin, I. I.
Prikhod'ko, S. S.
Zhuk, S. V.
Butylin, P. A.
Zaritskii, A. Yu.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 164 (04) : 569 - 575
[20] The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis
S-F Yip
C-C So
Ay-Y Chan
Hs-Y Liu
Ts-K Wan
L-C Chan
Leukemia, 2006, 20 : 1165 - 1165

← 1 2 3 4 5 →